High CXCL12 levels, potentially acting as protective shield toward CD8 TIL (by an unknown mechanism) (Vianello et al,2006; Guyon, 2014), may even further potentiate CD8 TIL exclusion from the tumor nest. This evidence concerns the gene CD8A and neoplasm.